Skip to main content
. 2021 May 5;30(1):11–16. doi: 10.1136/ejhpharm-2020-002597

Table 4.

Stability of carmustine (Carmustin Obvius, Carmubris) infusion solutions (0.20 mg/mL, 1.00 mg/mL) diluted in 5% glucose injection solution (freeflex PP/PE bags), stored at 22°C for 11 hours under light protection

Carmustine-containing medicinal product Initial carmustine concentration
(mg/mL)±RSD (%)
% Initial carmustine concentration remaining±RSD (%) (n=9)
Measured concentration 0 hour=100%
Nominal Measured 3.5 hours 6 hours 8.5 hours 11 hours
Carmustin Obvius 0.2 0.2038 (±1.36) 96.47 (±0.51) 93.39 (±0.52) 91.07 (±0.39) 88.68 (±0.38)
Carmubris 0.2045 (±1.16) 96.08 (±0.31) 93.57 (±0.49) 91.36 (±0.30) 88.88 (±0.32)
Carmustin Obvius 1.0 0.9855 (±1.28) 96.41 (±0.86) 94.59 (±0.64) 92.14 (±0.76) 89.99 (±0.69)

The remaining carmustine concentration is expressed as mean±RSD percentage rate (%) of nine measurements per time point (n=9).

RSD, relative standard deviation.